1.
Helicobacter Infection in Liver Tissue from Patients with Primary Liver Carcinoma;
肝癌患者肝组织中螺杆菌感染的研究
2.
An Analysis of Biochemical Parameter for Liver Reserve Function in Patients with Liver Cancer
肝癌患者肝脏储备功能生化指标分析
3.
Primary hepatic cancers are always complicated with portal venous tumor emboli in an incidence of 62.2%-90.2%.
原发性肝癌患者常合并门静脉癌栓。
4.
Survey of familial history of primary hepatic carcinoma patients in high risk areas
肝癌高发区原发性肝癌患者家族史调查
5.
The positive rate of combined determination of TNF-a and LSA was 97.3% in HCC.
在肝癌患者中两者的总阳性率达 97.3 %。
6.
The Effect of Qinggan Huayu Recipe on Primary Liver Cancer Patients and the Inhibition of Drug Serum of Liver Cancer Patients to Hepatoma Cells
清肝化瘀方药对原发性肝癌患者的疗效及肝癌患者含药血清对肝癌细胞增殖的抑制作用
7.
Detection of Osteopontin in Serum of Patients with Gastric, Rectocolonic or Hepatic Cancer;
胃癌、大肠癌或肝癌患者血清骨桥蛋白的检测
8.
Analysis on the Effectiveness in the Application of DDS in Hepatocellular Carcinoma Patients
DDS在肝癌患者中应用的效果分析
9.
Eff icacy of the IZL-2003 immunotherapeutic system in patients with liver cancer: an analysis of 40 cases
IZL-2003免疫治疗系统治疗肝癌患者40例
10.
Detection and evaluation of erythrocyte immune function of patients with liver cancer
肝癌患者红细胞免疫功能检测及评价
11.
Comparison of coagulative function between patients with liver cirrhosis and those with cirrhosis complicated with hepatocellular carcinoma receiving liver transplantation
肝硬化合并肝癌患者与病毒性肝炎肝硬化患者行肝移植术时凝血功能变化的比较
12.
The Study of Midkine and CD34 Expressions in the Tissue and Midkine Expression in the Serum of Patients with Primary Hepatocarcinoma;
肝癌患者癌组织MK、CD34及外周血中MK的表达研究
13.
Analyze the phenotype of DCs of healthy donors and patients with HCC
健康志愿者与肝癌患者体外诱导DC表型的检测
14.
Detecting Micro Hepatocellular Cancer Cells in Peripheral Blood of the Patients with Hepatocellular Carcinoma and Its Clinical Significance;
肝癌患者外周血中微量肝癌细胞的检测及临床意义
15.
Studies on Systemic Cell-mediated Immunity in Patients with Hepatocellular Carcinoma and the Immunological Influence of Liver Cancer Resection.;
肝癌患者细胞免疫状态的研究及肝癌切除对细胞免疫的影响
16.
Overall 7.4% of patients developed a hepatocellular carcinoma.
最后有7.4％的患者发生为肝细胞肝癌。
17.
Liver transplantation for recurrence after resection for hepatocellular carcinoma
原发性肝癌肝切除术后复发患者的肝移植治疗
18.
Many of the other sufferers will develop liver cancer.
其他患者有相当数目发展成肝癌。